A 76-Year-Old Man with Relapsed DLBCL

Laurie Sehn, MD, presents the case of a 76-year-old man with relapsed diffuse B-cell lymphoma and highlights the treatment options available to patients.

EP. 1: Case Presentation: A 76-Year-Old Man with Relapsed Diffuse Large B-Cell Lymphoma

July 23rd 2021

Laurie Sehn, MD, presents the case of a 76-year-old man with relapsed/refractory diffuse large B-cell lymphoma.

EP. 2: First-Line Therapy Options in Diffuse Large B-Cell Lymphoma

July 23rd 2021

An expert hematologist-oncologist describes risk assessment for diffuse large B-cell lymphoma, as well as first-line therapy selection based on risk and other factors.

EP. 3: Options for Second-Line Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

July 23rd 2021

Dr Laurie Sehn reviews the NCCN guidelines for second-line therapy in relapsed/refractory diffuse large B-cell lymphoma and discusses the clinical trial data for a recently approved new treatment combination.

EP. 4: Novel Therapies in Development for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

July 23rd 2021

A key opinion leader reviews novel therapies for diffuse large B-cell lymphoma.

EP. 5: Future Directions for Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

July 23rd 2021

Laurie Sehn, MD, discusses the unmet needs and future directions in the treatment of relapsed/refractory diffuse large B-cell lymphoma.